Skip to content

A prospective cohort study of Chinese medicine intervention in overweight/obese patients with abnormal glucose tolerance (IGT)

A prospective cohort study of Chinese medicine intervention in overweight/obese patients with abnormal glucose tolerance (IGT)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040015
Enrollment
Unknown
Registered
2020-11-18
Start date
2020-11-20
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Sponsors

The Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 75 years; 2) Meet the diagnostic criteria of Western medicine for IGT; 3) Meet the diagnostic criteria of western medicine for overweight/obese or central obesity; 4) Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1) Patients who have been diagnosed with type 1 diabetes, type 2 diabetes, gestational diabetes, secondary diabetes and other special types of diabetes; 2) People who have used hypoglycemic drugs continuously in recent 3 months; 3) Patients with severe other diseases or mental disorders; 4) Allergic to the known ingredients of the study drug and allergic constitution; 5) Pregnant or lactating women and those who have recently had family planning; 6) Patients with impaired liver and kidney function (ALT and AST are twice higher than the upper limit of normal value, and serum creatinine is abnormal).

Design outcomes

Primary

MeasureTime frame
Incidence of diabetes mellitus;HbA1c;Fasting plasma glucose;2h postprandial blood glucose;Fasting insulin;Insulin resistance index;

Secondary

MeasureTime frame
BMI;WC;WHR;Four items of blood lipid;TCM syndrome score;

Countries

China

Contacts

Public ContactXiuge Wang

The Affiliated Hospital of Changchun University of Chinese Medicine

362730191@qq.com+86 0431-86177011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026